Intravenous Iodinated Contrast Media: Indications and Risks

Adverse Contrast Reactions

Adverse reactions to modern non-ionic, low-osmolar contrast media are broadly classified into two pathophysiological mechanisms.

• Chemotoxic Reactions (Dose-Dependent): Expected physiological responses tied directly to the physical properties of the contrast, such as osmolality or sheer volume. This includes transient sensations of warmth, a metallic taste in the mouth, vasovagal responses, and most critically, Contrast-Induced Nephropathy (CIN).
• Idiosyncratic Reactions (Dose-Independent): Anaphylactoid, immune-mediated allergic responses that occur unpredictably. They vary from mild cutaneous symptoms (scattered urticaria, pruritus) to severe, life-threatening cardiopulmonary collapse (bronchospasm, laryngeal edema, profound hypotension).

Contrast-Induced Nephropathy (CIN)

CIN is an acute decline in renal function following contrast administration in the absence of an alternative etiology.

• Pathogenesis: Caused by intense renal medullary vasoconstriction leading to ischemic cellular injury, combined with direct direct tubular toxicity from the contrast molecules.
• Risk Factors: The primary predisposing risk factor is pre-existing renal impairment (an estimated Glomerular Filtration Rate < 30 mL/min). Concomitant diabetes mellitus, severe dehydration, and the use of nephrotoxic medications (such as NSAIDs or Metformin) exacerbate the risk.
• Prevention: The single most effective prophylactic strategy is aggressive intravenous volume expansion with normal saline prior to and following the contrast load.